A randomized controlled clinical trial comparing ventricular fibrillation detection time between two transvenous defibrillator models

PACE - Pacing and Clinical Electrophysiology

Volumn 22, Issue 7, 1999, Pages 990-998

  Kühlkamp, Volker ^a   Mortensen, P ^b   Kirstein, P ^b   Den Dulk, K ^b   Hoffman, E ^b   Wilber, D ^b   Higgins, S ^b   Kuhl M ^b  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b NONE

Author keywords

Dual chamber pacing; Implantable cardioverter defibrillator; Sensing of ventricular fibrillation; Ventricular fibrillation

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEFIBRILLATOR; HEART ATRIUM ARRHYTHMIA; HEART PACING; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; DEFIBRILLATORS, IMPLANTABLE; ELECTROCARDIOGRAPHY; EQUIPMENT DESIGN; EQUIPMENT FAILURE ANALYSIS; FEMALE; HEART RATE; HUMANS; MALE; MIDDLE AGED; TREATMENT OUTCOME; VENTRICULAR FIBRILLATION;

EID: 0032790052     PISSN: 01478389     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8159.1999.tb00562.x     Document Type: Article

References (16)

1. 1. Hochleitner M, Hörtnagl H, Ng C-K, et al. Usefulness of physiologic dual-chamber pacing in drug-resistant idiopathic dilated cardiomyopathy. Am J Cardiol 1990; 66:198-202.
2. 2. Andersen HR, Thuesen L, Bagger JP, et al. A prospective randomised trial of atrial versus ventricular pacing in sick sinus syndrome. Lancet 1994; 344:1523-1528.
3. 3. Brecker SJD, Xiao HB, Sparrow J, et al. Effects of dual chamber pacing with short atrioventricular delay in dilated cardiomyopathy. Lancet 1992; 340:1308-1312.
4. 4. Linde C, Gadler F, Edner M, et al. Results of atrioventricular synchronous pacing with optimized delay in patients with severe congestive heart failure. Am J Cardiol 1995; 75:919-923.
5. 5. Hochleitner M, Hörtnagl H, Fridrich I, et al. Long-term efficacy of physiologic dual-chamber pacing in the treatment of end stage idiopathic dilated cardiomyopathy. Am J Cardiol 1992; 70:1320-1325.
6. 6. Jeanrenaud X, Goy JJ, Kappenberger L. Effects of dual-chamber pacing in hypertrophic obstructive cardiomyopathy. Lancet 1992; 339:1318-1323.
7. 7. Cannon RO III, Tripodi D, Dilsizian V, et al. Results of permanent dual chamber pacing in symptomatic nonobstructive hypertrophic cardiomyopathy. Am J Cardiol 1994; 73:571-576.
8. 8. Epstein AE, Kay GN, Plumb VJ, et al. Combined automatic implantable cardioverter-defibrillator systems: Implantation techniques and follow-up. J Am Coll Cardiol 1989; 13:121-131.
9. 9. Brooks DR, Garan H, McGovern BA, et al. Implantation of transvenous cardioverters-defibrillator systems in patients with permanent endocardial pacemakers. Am Heart J 1995; 129:45-53.
10. 10. Barold SS. The fourth decade of cardiac pacing: Optimal modes of stimulation. Prim Cardiol 1993; 19:16-32.
11. 11. Grimm W, Flores BT, Marchlinski FE. Electrocardiographically documented unnessary, spontaneous shocks in 241 patients with implantable cardioverter defibrillator. PACE 1992; 15:1667-1673.
12. 12. Wood MA, Stambler BS, Diamino RJ, et al. Lessons learned from data logging in a multicenter clinical trial using a late-generation implantable cardioverter-defibrillator. J Am Coll Cardiol 1994; 24:1692-1699.
13. 13. Calkins H, Brinker J, Veltri EP, et al. Clinical interactions between pacemakers and automatic cardioverter-defibrillators. J Am Coll Cardiol 1990; 16:666-673.
14. 14. Lavergne T, Daubert JP, Chauvin M, et al. Preliminary clinical experience with the first dual chamber pacemaker defibrillator. PACE 1997; 20:182-188.
15. 15. Pocock SJ. Crossover trials. In SJ Pocock (ed.): Clinical Trials. A Practical Approach. Chichester, John Wiley & Sons, 1983, pp. 110-122.
16. 16. Geelen P, Lorga F A, Chauvin M, et al. The value of DDD pacing in patients with an implantable cardioverter defibrillator. PACE 1997; 20:177-181.